{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T20:38:28Z","timestamp":1785357508778,"version":"3.55.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T00:00:00Z","timestamp":1578009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T00:00:00Z","timestamp":1578009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81473407"],"award-info":[{"award-number":["81473407"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s10620-019-06017-3","type":"journal-article","created":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T09:02:39Z","timestamp":1578042159000},"page":"2925-2936","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Astragaloside IV Synergizes with Ferulic Acid to Alleviate Hepatic Fibrosis in Bile Duct-Ligated Cirrhotic Rats"],"prefix":"10.1007","volume":"65","author":[{"given":"Xue-Mei","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ni","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5543-3354","authenticated-orcid":false,"given":"Ying-Cai","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,3]]},"reference":[{"key":"6017_CR1","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ejphar.2018.02.051","volume":"826","author":"MM Ni","year":"2018","unstructured":"Ni MM, Wang YR, Wu WW, et al. Novel Insights on Notch signaling pathways in liver fibrosis. Eur J Pharmacol. 2018;826:66\u201374.","journal-title":"Eur J Pharmacol"},{"key":"6017_CR2","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.bpg.2017.04.005","volume":"31","author":"ME Zoubek","year":"2017","unstructured":"Zoubek ME, Trautwein C, Strnad P. Reversal of liver fibrosis: from fiction to reality. Best Pract Res Clin Gastroenterol. 2017;31:129\u2013141.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"6017_CR3","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","volume":"14","author":"T Tsuchida","year":"2017","unstructured":"Tsuchida T, Friedman SL. Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol. 2017;14:397\u2013411.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"6017_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","volume":"121","author":"T Higashi","year":"2017","unstructured":"Higashi T, Friedman SL, Hoshida Y. Hepatic stellate cells as key target in liver fibrosis. Adv Drug Deliv Rev. 2017;121:27\u201342.","journal-title":"Adv Drug Deliv Rev"},{"key":"6017_CR5","doi-asserted-by":"publisher","first-page":"4302","DOI":"10.1074\/jbc.M116.773085","volume":"292","author":"LY Tang","year":"2017","unstructured":"Tang LY, Heller M, Meng Z, et al. Transforming growth factor-\u03b2 (TGF-\u03b2) directly activates the JAK1-STAT3 axis to induce hepatic fibrosis in coordination with the SMAD pathway. J Biol Chem. 2017;292:4302\u20134312.","journal-title":"J Biol Chem"},{"key":"6017_CR6","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.intimp.2018.01.027","volume":"56","author":"X Chen","year":"2018","unstructured":"Chen X, Ying X, Sun W, et al. The therapeutic effect of fraxetin on ethanol-induced hepatic fibrosis by enhancing ethanol metabolism, inhibiting oxidative stress and modulating inflammatory mediators in rats. Int Immunopharmacol. 2018;56:98\u2013104.","journal-title":"Int Immunopharmacol"},{"key":"6017_CR7","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ejphar.2013.12.033","volume":"724","author":"GJ den Hartog","year":"2014","unstructured":"den Hartog GJ, Qi S, van Tilburg JH, et al. Superoxide anion radicals activate hepatic stellate cells after entry through chloride channels: a new target in liver fibrosis. Eur J Pharmacol. 2014;724:140\u2013144.","journal-title":"Eur J Pharmacol"},{"key":"6017_CR8","first-page":"984","volume":"20","author":"A Matkowski","year":"2013","unstructured":"Matkowski A, Jamio\u0142kowska-Kozlowska W, Nawrot I. Chinese medicinal herbs as source of antioxidant compounds\u2014where tradition meets the future. Curr Med Chem. 2013;20:984\u20131004.","journal-title":"Curr Med Chem"},{"key":"6017_CR9","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1021\/acschemneuro.7b00247","volume":"9","author":"Q Li","year":"2018","unstructured":"Li Q, Niu C, Zhang X, et al. Gastrodin and isorhynchophylline synergistically inhibit MPP+-induced oxidative stress in SH-SY5Y cells by targeting ERK1\/2 and GSK-3\u03b2 pathways: involvement of Nrf2 nuclear translocation. ACS Chem Neurosci. 2018;9:482\u2013493.","journal-title":"ACS Chem Neurosci"},{"key":"6017_CR10","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.fitote.2010.04.007","volume":"81","author":"P Wang","year":"2010","unstructured":"Wang P, Liang YZ. Chemical composition and inhibitory effect on hepatic fibrosis of Danggui Buxue Decoction. Fitoterapia. 2010;81:793\u2013798.","journal-title":"Fitoterapia"},{"key":"6017_CR11","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.freeradbiomed.2013.02.027","volume":"60","author":"X Li","year":"2013","unstructured":"Li X, Wang X, Han C, et al. Astragaloside IV suppresses collagen production of activated hepatic stellate cells via oxidative stress-mediated p38 MAPK pathway. Free Radic Biol Med. 2013;60:168\u2013176.","journal-title":"Free Radic Biol Med"},{"key":"6017_CR12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.bcp.2014.10.016","volume":"93","author":"T Xu","year":"2015","unstructured":"Xu T, Pan Z, Dong M, Yu C, Niu Y. Ferulic acid suppresses activation of hepatic stellate cells through ERK1\/2 and Smad signaling pathways in vitro. Biochem Pharmacol. 2015;93:49\u201358.","journal-title":"Biochem Pharmacol"},{"key":"6017_CR13","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1039\/C5NP00005J","volume":"32","author":"M Kibble","year":"2015","unstructured":"Kibble M, Saarinen N, Tang J, et al. Network pharmacology applications to map the unexplored target space and therapeutic potential of natural products. Nat Prod Rep. 2015;32:1249\u20131266.","journal-title":"Nat Prod Rep"},{"key":"6017_CR14","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1080\/10715762.2017.1290233","volume":"51","author":"H Dong","year":"2017","unstructured":"Dong H, Guo H, Liang Y, et al. Astragaloside IV synergizes with ferulic acid to suppress hepatic stellate cells activation in vitro. Free Radic Res. 2017;51:167\u2013178.","journal-title":"Free Radic Res"},{"key":"6017_CR15","doi-asserted-by":"publisher","first-page":"418","DOI":"10.5604\/16652681.1198820","volume":"15","author":"AS Zepeda-Morales","year":"2016","unstructured":"Zepeda-Morales AS, Del Toro-Arreola S, Garc\u00eda-Benavides L, et al. Liver fibrosis in bile duct-ligated rats correlates with increased hepatic IL-17 and TGF-\u03b22 expression. Ann Hepatol. 2016;15:418\u2013426.","journal-title":"Ann Hepatol"},{"key":"6017_CR16","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1111\/j.1476-5381.2011.01206.x","volume":"162","author":"LQ Meng","year":"2011","unstructured":"Meng LQ, Tang JW, Wang Y, et al. Astragaloside IV synergizes with ferulic acid to inhibit renal tubulointerstitial fibrosis in rats with obstructive nephropathy. Br J Pharmacol. 2011;162:1805\u20131818.","journal-title":"Br J Pharmacol"},{"key":"6017_CR17","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/S0140-6736(96)07642-8","volume":"349","author":"T Poynard","year":"1997","unstructured":"Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet. 1997;349:825\u2013832.","journal-title":"Lancet"},{"key":"6017_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ntt.2014.08.007","volume":"46","author":"C Li","year":"2014","unstructured":"Li C, Pan Z, Xu T, et al. Puerarin induces the upregulation of glutathione levels and nuclear translocation of Nrf2 through PI3K\/Akt\/GSK-3\u03b2 signaling events in PC12 cells exposed to lead. Neurotoxicol Teratol. 2014;46:1\u20139.","journal-title":"Neurotoxicol Teratol"},{"key":"6017_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11010-014-2258-1","volume":"400","author":"L Zhang","year":"2015","unstructured":"Zhang L, Liu C, Meng XM, et al. Smad2 protects against TGF-\u03b21\/Smad3-mediated collagen synthesis in human hepatic stellate cells during hepatic fibrosis. Mol Cell Biochem. 2015;400:17\u201328.","journal-title":"Mol Cell Biochem"},{"key":"6017_CR20","first-page":"81","volume":"18","author":"MF McCarty","year":"2018","unstructured":"McCarty MF, O\u2019Keefe JH, DiNicolantonio JJ. Dietary glycine is rate-limiting for glutathione synthesis and may have broad potential for health protection. Ochsner J. 2018;18:81\u201387.","journal-title":"Ochsner J"},{"key":"6017_CR21","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/bs.acc.2014.11.001","volume":"68","author":"G Bresciani","year":"2015","unstructured":"Bresciani G, da Cruz IB, Gonz\u00e1lez-Gallego J. Manganese superoxide dismutase and oxidative stress modulation. Adv Clin Chem. 2015;68:87\u2013130.","journal-title":"Adv Clin Chem"},{"key":"6017_CR22","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.fct.2018.03.029","volume":"115","author":"M Liang","year":"2018","unstructured":"Liang M, Wang Z, Li H, et al. l-Arginine induces antioxidant response to prevent oxidative stress via stimulation of glutathione synthesis and activation of Nrf2 pathway. Food Chem Toxicol. 2018;115:315\u2013328.","journal-title":"Food Chem Toxicol"},{"key":"6017_CR23","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1002\/hep.29319","volume":"66","author":"T Chida","year":"2017","unstructured":"Chida T, Ito M, Nakashima K, et al. Critical role of CREBH-mediated induction of transforming growth factor \u03b22 by hepatitis C virus infection in fibrogenic responses in hepatic stellate cells. Hepatology. 2017;66:1430\u20131443.","journal-title":"Hepatology"},{"key":"6017_CR24","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1369\/0022155415627681","volume":"64","author":"F Xu","year":"2016","unstructured":"Xu F, Liu C, Zhou D, et al. TGF-\u03b2\/SMAD pathway and its regulation in hepatic fibrosis. J Histochem Cytochem. 2016;64:157\u2013167.","journal-title":"J Histochem Cytochem"},{"key":"6017_CR25","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.omtn.2017.06.022","volume":"8","author":"JY Kim","year":"2017","unstructured":"Kim JY, An HJ, Kim WH, et al. Anti-fibrotic effects of synthetic oligodeoxynucleotide for TGF-\u03b21 and Smad in an animal model of liver cirrhosis. Mol Ther Nucleic Acids. 2017;8:250\u2013263.","journal-title":"Mol Ther Nucleic Acids"},{"key":"6017_CR26","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.biopha.2017.01.107","volume":"88","author":"R Ma","year":"2017","unstructured":"Ma R, Chen J, Liang Y, et al. Sorafenib: a potential therapeutic drug for hepatic fibrosis and its outcomes. Biomed Pharmacother. 2017;88:459\u2013468.","journal-title":"Biomed Pharmacother"},{"key":"6017_CR27","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1159\/000456581","volume":"35","author":"JP Iredale","year":"2017","unstructured":"Iredale JP, Pellicoro A, Fallowfield JA. Liver fibrosis: understanding the dynamics of bidirectional wound repair to inform the design of markers and therapies. Dig Dis. 2017;35:310\u2013313.","journal-title":"Dig Dis"},{"key":"6017_CR28","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.gtc.2017.01.004","volume":"46","author":"DE Kleiner","year":"2017","unstructured":"Kleiner DE. Drug-induced liver injury: the hepatic pathologist\u2019s approach. Gastroenterol Clin N Am. 2017;46:273\u2013296.","journal-title":"Gastroenterol Clin N Am"},{"key":"6017_CR29","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1038\/labinvest.2016.112","volume":"96","author":"LL Kennedy","year":"2016","unstructured":"Kennedy LL, Meng F, Venter JK, et al. Knockout of microRNA-21 reduces biliary hyperplasia and liver fibrosis in cholestatic bile duct ligated mice. Lab Invest. 2016;96:1256\u20131267.","journal-title":"Lab Invest"},{"key":"6017_CR30","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/S2468-1253(16)30110-8","volume":"1","author":"P Ramachandran","year":"2016","unstructured":"Ramachandran P, Henderson NC. Antifibrotics in chronic liver disease: tractable targets and translational challenges. Lancet Gastroenterol Hepatol. 2016;1:328\u2013340.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"6017_CR31","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s13337-013-0182-8","volume":"25","author":"SA Gabr","year":"2014","unstructured":"Gabr SA, Alghadir AH. Prediction of fibrosis in hepatitis C patients: assessment using hydroxyproline and oxidative stress biomarkers. Virusdisease. 2014;25:91\u2013100.","journal-title":"Virusdisease"},{"key":"6017_CR32","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3177\/jnsv.63.35","volume":"63","author":"XY Han","year":"2017","unstructured":"Han XY, Hu JN, Wang Z, et al. 5-HMF attenuates liver fibrosis in CCl4-plus-alcohol-induced mice by suppression of oxidative stress. J Nutr Sci Vitaminol (Tokyo). 2017;63:35\u201343.","journal-title":"J Nutr Sci Vitaminol (Tokyo)"},{"key":"6017_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tox.2018.01.007","volume":"396\u2013397","author":"H Yan","year":"2018","unstructured":"Yan H, Huang Z, Bai Q, et al. Natural product andrographolide alleviated APAP-induced liver fibrosis by activating Nrf2 antioxidant pathway. Toxicology. 2018;396\u2013397:1\u201312.","journal-title":"Toxicology"},{"key":"6017_CR34","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.bbamcr.2018.02.010","volume":"1865","author":"I Bellezza","year":"2018","unstructured":"Bellezza I, Giambanco I, Minelli A, et al. Nrf2-Keap1 signaling in oxidative and reductive stress. Biochim Biophys Acta. 2018;1865:721\u2013733.","journal-title":"Biochim Biophys Acta"},{"key":"6017_CR35","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/S0083-6729(07)76021-1","volume":"76","author":"A Di Sario","year":"2007","unstructured":"Di Sario A, Candelaresi C, Omenetti A, et al. Vitamin E in chronic liver diseases and liver fibrosis. Vitam Horm. 2007;76:551\u2013573.","journal-title":"Vitam Horm"},{"key":"6017_CR36","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.freeradbiomed.2013.07.036","volume":"66","author":"J Lu","year":"2014","unstructured":"Lu J, Holmgren A. The thioredoxin antioxidant system. Free Radic Biol Med. 2014;66:75\u201387.","journal-title":"Free Radic Biol Med"},{"key":"6017_CR37","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jnutbio.2017.09.025","volume":"52","author":"B Liu","year":"2018","unstructured":"Liu B, Jiang H, Lu J, et al. Grape seed procyanidin extract ameliorates lead-induced liver injury via miRNA153 and AKT\/GSK-3\u03b2\/Fyn-mediated Nrf2 activation. J Nutr Biochem. 2018;52:115\u2013123.","journal-title":"J Nutr Biochem"},{"key":"6017_CR38","doi-asserted-by":"publisher","first-page":"569","DOI":"10.15252\/embr.201643068","volume":"18","author":"B Anderton","year":"2017","unstructured":"Anderton B, Camarda R, Balakrishnan S, et al. MYC-driven inhibition of the glutamate-cysteine ligase promotes glutathione depletion in liver cancer. EMBO Rep. 2017;18:569\u2013585.","journal-title":"EMBO Rep"},{"key":"6017_CR39","first-page":"316","volume":"62","author":"R Sacco","year":"2016","unstructured":"Sacco R, Eggenhoffner R, Giacomelli L. Glutathione in the treatment of liver diseases: insights from clinical practice. Minerva Gastroenterol Dietol. 2016;62:316\u2013324.","journal-title":"Minerva Gastroenterol Dietol"},{"key":"6017_CR40","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.3892\/etm.2017.4836","volume":"14","author":"SP Wu","year":"2017","unstructured":"Wu SP, Yang Z, Li FR, et al. Smad7-overexpressing rat BMSCs inhibit the fibrosis of hepatic stellate cells by regulating the TGF-\u03b21\/Smad signaling pathway. Exp Ther Med. 2017;14:2568\u20132576.","journal-title":"Exp Ther Med"},{"key":"6017_CR41","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrneph.2016.48","volume":"12","author":"XM Meng","year":"2016","unstructured":"Meng XM, Nikolic-Paterson DJ, Lan HY. TGF-\u03b2: the master regulator of fibrosis. Nat Rev Nephrol. 2016;12:325\u2013338.","journal-title":"Nat Rev Nephrol"},{"key":"6017_CR42","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1021\/acs.jnatprod.7b00737","volume":"81","author":"LF Nothias","year":"2018","unstructured":"Nothias LF, Nothias-Esposito M, da Silva R, et al. Bioactivity-based molecular networking for the discovery of drug leads in natural product bioassay-guided fractionation. J Nat Prod. 2018;81:758\u2013767.","journal-title":"J Nat Prod"},{"key":"6017_CR43","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.biopha.2018.02.064","volume":"101","author":"SM Eraky","year":"2018","unstructured":"Eraky SM, El-Mesery M, El-Karef A, et al. Silymarin and caffeine combination ameliorates experimentally-induced hepatic fibrosis through down-regulation of LPAR1 expression. Biomed Pharmacother. 2018;101:49\u201357.","journal-title":"Biomed Pharmacother"},{"key":"6017_CR44","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/med.21444","volume":"38","author":"M Isgut","year":"2018","unstructured":"Isgut M, Rao M, Yang C, et al. Application of combination high-throughput phenotypic screening and target identification methods for the discovery of natural product-based combination drugs. Med Res Rev. 2018;38:504\u2013524.","journal-title":"Med Res Rev"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-019-06017-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-019-06017-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-019-06017-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T15:21:51Z","timestamp":1650122511000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-019-06017-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,3]]},"references-count":44,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["6017"],"URL":"https:\/\/doi.org\/10.1007\/s10620-019-06017-3","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,3]]},"assertion":[{"value":"2 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"None declared.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}